Lobeglitazone attenuates fibrosis in corneal fibroblasts by interrupting TGF-beta-mediated Smad signaling.

Selikem NuwormegbeNa-Young ParkSun Woong Kim

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)

These findings indicate that lobeglitazone may be a promising therapeutic agent for corneal scarring. KEY MESSAGES.

Keyphrases

transforming growth factor
optical coherence tomography
wound healing
epithelial mesenchymal transition
cataract surgery
extracellular matrix
signaling pathway